Related Experiment Video
Updated: Aug 6, 2026
08:48
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Round and round we go: cyclic peptides in disease
Maria Katsara1, Theodore Tselios, Spyros Deraos
1Burnet Institute at Austin, Immunology and Vaccine Laboratory, Heidelberg, VIC, Australia.
Current Medicinal Chemistry
|August 22, 2006
Summary
Cyclic peptides show promise as therapeutic agents for infectious diseases, autoimmunity, and cancer due to enhanced stability and properties. This review highlights their potential in treating various conditions.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Discovery
Background:
- Novel therapeutic agents are crucial for treating infectious diseases, autoimmune disorders, and cancer.
- Cyclic peptides represent a significant class of compounds with established therapeutic applications, including penicillin and vancomycin.
- Compared to linear peptides, cyclic peptides offer improved stability, receptor selectivity, and pharmacodynamic properties, enhancing their therapeutic potential.
Purpose of the Study:
- To review the therapeutic potential of cyclic peptides in disease treatment.
- To highlight the advantages of cyclic peptides over linear peptides for drug development.
- To provide an overview of current and potential applications of cyclic peptides in medicine.
Main Methods:
- Literature review of cyclic peptides in therapeutic applications.
- Analysis of chemical and enzymatic stability of cyclic peptides.
- Evaluation of receptor selectivity and pharmacodynamic properties of cyclic peptides.
Main Results:
- Cyclic peptides demonstrate broad therapeutic potential across various diseases.
- Established cyclic peptides like penicillin and vancomycin are effective treatments.
- Emerging applications include use as synthetic immunogens, ion channels, and vaccines for autoimmune diseases.
Conclusions:
- Cyclic peptides are valuable therapeutic agents with significant potential for treating infectious diseases, autoimmunity, and cancer.
- Their inherent stability and favorable properties make them attractive candidates for drug development.
- Further research into cyclic peptides could lead to novel treatments for a range of challenging diseases.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
01:24Intracellular Signaling Cascades
Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...